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Skin  tags  (ST)  are the  most  common  ﬁbro-epithelial  skin  tumors.  They  are  tumors  of  the
middle-aged  and  elderly  people.  However,  in women,  the  age  of 50 is suggested  to  be  the
turning  point  of  life  at which  the  development  of  skin  tags  comes  to  a  stop.  A major  event
that  occurs  around  this  period  of  life  is menopause/andropause,  after  menopause,  estrogen
receptors  amounts  decrease  signiﬁcantly.  Estrogen  receptors  (ER)  and  androgen  receptors
(AR) are  members  of the  steroid  receptor  gene  superfamily.  Estrogen  receptors  positivity
has been  demonstrated  in most  skin  tumors  by  both  histochemical  and  biochemical  assays.
This study  aimed  to assess  the role  of estrogen  and  androgen  receptors  in  the  develop-
ment  of  skin  tags  by assessment  of their  immunohistochemical  expression.  Twenty  ﬁve
patients  were  included  in  this  study.  Snip  excision  of  skin  tags  was  done  for each  patient,
punch  biopsy  from  adjacent  sites  from  skin  tags  have  been  taken  as  perilesional  skin biopsy
only for  twelve  patients.  Histopathology  was  performed  to conﬁrm  the  diagnosis.  Immuno-
histochemical  staining  was  done  to  detect  ER  and  AR  for skin  tags,  perilesional  skin, and
control  normal  skin.Immunohistochemical staining  for ER  was  positive  in  64%  of skin  tag  cases  and AR  were
positive  in  60%  of  them.  There was  a statistically  signiﬁcant  difference  in ER and  AR  staining
pattern  between  skin  tags, perilesional  skin  and  normal  skin.  It could  be concluded  that ST
correlated  positively  with  ER  and AR  immunohistochemical  staining  which  may  implicate
a  role  for  them  in the pathogenesis  of  skin  tags.1. Introduction
Skin tags (ST) are the most common ﬁbro-epithelial skin
tumors.  They are small ﬂesh colored to dark brown ses-
sile  or pedunculated papillomas, composed of loose ﬁbrous
tissue.  They grow in the natural folds of the skin such as
neck,  axillae, inguinal, thigh, perineal and inframammary
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regions. They tend to grow progressively in size and do not
involute  spontaneously [1]. Etiology of skin tags includes,
insulin resistance and insulin like growth factor [2], hor-
monal  factor [3,4], high mast cell count [5], and human
papilloma virus [6].
Skin  tags are tumors of the middle-aged and elderly
people, and they are very common, particularly in women
at  the menopause. Skin tags may  be aggravated during
Open access under CC BY-NC-ND license. pregnancy and may  resolve post partum [4]. However, in
women,  the age of 50 is suggested to be the turning point
of  life at which the development of skin tags comes to a
stop.  A major event that occurs around this period of life is
access under CC BY-NC-ND license. 
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enopause/andropause, after menopause, estrogen recep-
ors  amounts decrease signiﬁcantly [7].
Estrogen receptors (ER) are class I members of the
teroid receptor gene superfamily, which includes the
ndrogen receptors (ARs), progesterone receptors, glu-
ocorticoid receptors, thyroid hormone receptors and
etinoic acid receptors, they are deﬁned as ligand-inducible
ranscription factors [8]. All receptors of the nuclear
eceptor superfamily have a similar architecture with inde-
endent  but interacting functional domains [9]. There are
wo  subtypes of ER; estrogen receptor-alpha (ER) and
strogen receptor-beta (ER). Both ER and ER bind
7-estradiol with high afﬁnity [10]. Estradiole binds
o  keratinocytes with high afﬁnity, and in its normal
hysiological range increases the regulation of the level
f  ER receptors and induces keratinocyte proliferation
11]. In addition, estrogen targets human skin ﬁbroblasts.
7-Estradiol has been shown to increase ﬁbroblast prolif-
ration  in human skin [12].
ER is more widely distributed within the skin and skin
tructures than ER [13]. The variation in distribution of
eceptors within the skin suggests that each has a dif-
erent, cell-speciﬁc role [14]. ER and ER co-express in
uman  skin ﬁbroblasts and likely play a role in the reg-
lation of estrogen action in the skin [15]. The presence
f estrogen receptor in some skin tumors has led to sev-
ral  studies assessing the association between sex hormone
tatus  and cutaneous malignancies. Estrogen receptor pos-
tivity  has been demonstrated in most skin tumors by both
istochemical and biochemical assays [16].
.1. Aim of the work
This  study aimed to assess the role of estrogen and
ndrogen receptors in the development of skin tags by
ssessment of their immunohistochemical expression.
.2. Patients and methods
Twenty  ﬁve patients were included in this study. They
ere  selected from the out-patient clinic of Dermatology
nd Venereology Department, Tanta university hospital
uring the period from April 2011 to October 2012.
nformed consent was taken from all the patients and also
pproval from the research ethics committee was done.
atients perceiving sex steroid hormonal therapy have
een  excluded. For all subjects the followings were done;
horough complete history taking, general and dermato-
ogical examination, estimation of body mass index, snip
xcision  of skin tags was  done for each patient, punch
iopsy of 2 mm size from adjacent sites from skin tags
ave  been taken as perilesional skin biopsy only for twelve
atients. Specimens were ﬁxed in 10% formalin. First,
ematoxylin and eosin stained histopathological sections
ere  performed to conﬁrm the diagnosis. Normal skin, as
arafﬁn  blocks which were of matching age, sex, and site to
he  patients group, has been collected to be used as controls
rom  twelve blocks. Immunohistochemical staining was
one  to detect ER and AR for skin tags, perilesional skin,
nd  control normal skin. Immunostaining was carried out
y  a standard streptavidin–biotin peroxidase techniquend Ultrastructure 1 (2013) 76–83 77
with diaminobenzidine chromogen. The antibody used
is  mouse monoclonal antihuman antibody for androgen
receptor and rabbit monoclonal antihuman antibody for
estrogen  receptor.
AR  positivity was deﬁned as nuclear staining while
cytoplasmic staining was non-speciﬁc. Tumors with 10%
or  more nuclear stained cells were considered positive
for  AR according to [17]. Estrogen receptors staining was
also  nuclear. In the nuclear staining, the percentage of
the  stained cells was determined and was scored using
[18]  scoring system. The staining reaction was  subdivided
according to the percentage of stained nuclei as follows:
Negative (0) = no nuclear immuonostaining, weak stain-
ing  (+1) = less than 10% positive nuclear staining, moderate
staining (+2) = 10–50% positive nuclear staining and strong
staining (+3) = more than 50% positive nuclear staining.
1.3. Statistics
Statistical presentation and analysis of the present
study was conducted, using the mean, standard deviation,
unpaired Student t-test, analysis of variance [ANOVA] test,
chi-square test and Monte-Carlo (MCp) test by computer
statistical program SPSS V, 16.
2. Results
In the current study, the age of skin tags cases ranged
from 17 to 65 years with mean age of 40.32 ± 14.01 years.
Correlation between skin tags number and age groups was
done,  it was statistically signiﬁcant (P = 0.030). There was
female  predominance; 20 cases were females and 5 were
males.  Neck (96%) and axilla (44%) respectively were the
most  common sites. Thirteen patients with skin tags (52%)
had  positive family history. All patients complained of dis-
ﬁguring  skin lesions (100%), four patients (16%) complained
of  itching, while only one patient (4%) complained of pain.
Body  mass index (BMI) has been calculated by this equa-
tion:  BMI  = weight (kg)/height (m2). In this study, 2 patients
(8%)  were normal (BMI: 18.5–24.9), 5 patients (20%) were
overweight (BMI: 25–29.9), 9 patients (36%) were obese
grade I (BMI: 30–34.9), 4 patients (16%) were obese grade
II  (BMI: 35–39.9), and 5 patients (20%) were obese grade III
(BMI:  40 and above) with a mean 2.20 ± SD 1.22 (Table 1).
Regarding medical condition in our study, the main
occurrence was  obesity in 18 patients (72%) then diabetes
mellitus in 7 patients (28%) and hypertension in 7 patients
(28%). Also there were other dermatologic diseases that
have  been observed in this study, the most common was
acanthosis nigricans in 8 patients (32%) (Table 2).
2.1.  Histopathological results
Heamatoxylin and eosin staining of skin specimens
sections showed that skin tags are histologically composed
of  loose collagen ﬁbers and dilated capillaries. The multiple
small  furrowed papules usually show papillomatosis, reg-
ular  acanthosis and hyperkeratosis. The common ﬁliform
smooth growths show slight to moderate acanthosis
and occasionally mild papillomatosis. The connective
tissue stalk is composed of loose collagen ﬁbers and
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Table 1
Distribution of the studied cases according to clinical data, site and BMI.
Clinical data No %
Sex
Male 5 20.0
Female 20 80.0
Age
Adult age (17–30) 8 32.0
Middle age (31–45) 8 32.0
Old age (46–65) 9 36.0
Family history
No  12 48.0
Yes 13 52.0
Complain
Disﬁguring 25 100.0
Painful 1 4.0
Itchy 4 16.0
Site
Neck 24 96.0
Axilla 11 44.0
Chest 3 12.0
Eye lid 2 8.0
Infra-mammary 1 4.0
Thigh 1 4.0
BMI
Normal 2 8.0
Over weight 5 20.0
Obese grade I 9 36.0
Obese grade II 4 16.0
Obese grade III 5 20.0
Table 2
Distribution of the studied cases according to other medical conditions
and associated dermatological diseases.
Medical condition No %
Obesity 18 72.0
Hypertension 7 28.0
Diabetes mellitus 7 28.0
Osteoarthritis 2 8.0
Chronic calcular cholcystitis 4 16.0
Liver cirrhosis 4 16.0
Miscelaneous 8 32.0
Free 8 32.0
Associated dermatological diseases
Acanthosis nigericans 8 32.0
Acne vulgaris 2 20.0
Alopecia 2 20.0
Pityriasis versi color 2 20.0
Melasma 2 20.0
Seborrhic. keratosis 1 10.0
Androgenetic alopecia 1 10.0
Nevi at neck 1 10.0
Filiform verruca 1 10.0
Fig. 1. A case of skin tag showing loose connective tissue core, hyperke-
ratosis and papillomatosis (H&E 100×).
Table 3
Comparison between the skin tag, perilesional skin and normal skin according to
Skin tags (n = 25) Perilesional skin
No % No 
ER
0 9 36.0 9 
+1 7 28.0 3 
+2  6 24.0 0 
+3  3 12.0 0 
AR  IHC staining
−ve  10 40.0 8 
+ve 15 60.0 4 
* Statistically signiﬁcant at P ≤ 0.05.Fig. 2. A case of skin tag showing loose connective tissue containing
dilated blood vessels and fat cells (H&E 200×).
often contains numerous dilated capillaries. Nevus cells
are  found in many of the ﬁlliform growths, indicating
that some of them represent involuting melanocytic nevi
(Figs.  1 and 2).
2.2.  Immunohistochemical results2.2.1. Estrogen receptors
After  conﬁrming our clinical diagnosis by Hematoxylin
and Eosin staining of all sections, immunohistochemical
 ER and AR immuonohistochemical (IHC) staining.
 (n = 12) Normal skin (n = 12) MCp
% No %
75.0 12 100.0 0.003*
25.0 0 0.0
0.0 0 0.0
0.0 0 0.0
66.6 12 100.0 0.001*
33.3 0 0.0
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ing  in skin tags. Regarding body mass index (BMI), estrogen
receptor staining revealed no relation with obesity grades,
however androgen receptor staining showed a signiﬁcantig. 3. Normal skin showing negative (0) staining for estrogen receptors
IHC 200×).
taining for estrogen receptor (ER) by rabbit monoclonal
ntihuman antibody was  done to all sections and staining
attern was nuclear. In the skin tags 9 cases (36%) were
0)  negative and 16 cases (64%) were positive. Moreover, in
he  perilesional skin 9 cases (75%) were (0) negative and 3
ases  (25%) were (+1) weakly stained. However the normal
kin  12 cases (100%) were all (0) negatively stained. There
as  a statistically signiﬁcant difference in estrogen recep-
ors  staining pattern between skin tags, perilesional skin
nd  normal skin (P = 0.003) (Table 3) (Figs. 2–8).
.2.2. Androgen receptors
Immunohistochemical staining for androgen receptor
AR) was done to all sections and staining pattern was
lso  nuclear. In the skin tags, 15 of cases (60%) were
ositively stained, and 10 of cases (40%) were negatively
tained. However, in the perilesional skin, 4 of cases
33, 3%) positively stained, and 8 of cases (66, 6%) were
egatively stained. In the control normal skin, androgen
eceptors were weakly stained as the target cells (follicular
eratinocytes, sebocytes) in all specimens stained but
ower  than 10%. So according to the scoring system, these
pecimens were 100% negatively stained for androgen
eceptors. There was a statistically signiﬁcant difference in
ig. 4. A perilesional skin showing negative (0) staining for estrogen
eceptors (IHC 400×).Fig. 5. A perilesional skin showing mild positive (+1) nuclear staining of
estrogen receptors (IHC 400×).
staining pattern between skin tags, perilesional skin and
normal  skin (P = 0.001) (Table 3) (Figs. 9–11).
It was noticed that no correlation between age and sex
and  estrogen receptor staining or androgen receptor stain-Fig. 6. A case of skin tag showing mild (+1) nuclear staining of estrogen
receptors (IHC 400×).
Fig. 7. A case of skin tag showing moderate (+2) nuclear staining of estro-
gen receptors (IHC 400×).
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Fig. 8. A case of skin tag showing strong positive (+3) nuclear staining for
estrogen receptors (IHC 400×).
Fig. 9. Normal skin showing negative staining for androgen receptors (IHC
200×).Fig. 10. A case of skin tag showing positive nuclear staining of androgen
receptors (IHC 400×).
relation with BMI  (P = 0.017). In a correlation between DM
and  both ER and AR immunostaining, there was no sig-
niﬁcant relation between estrogen or androgen receptors
and  DM in patients with skin tags. Regarding acanthosis
nigricance (AN), which were associated with skin tags in 8
patients,  there was no relation between estrogen or andro-
gen  receptors and AN association with ST.
Correlation between site and estrogen receptor staining
revealed no signiﬁcant relation between them. More-
over, there was no signiﬁcant relation between site andFig. 11. A case of skin tag showing negative nuclear staining of androgen
receptors (IHC 400×).
androgen receptor staining (Table 4). Considering the num-
ber  of skin tags and estrogen receptor staining, there was
no  relation in the current study between them. A similar
result has been obtained from correlation between number
of  skin tags and androgen receptor staining (Table 5).
3.  Discussion
As skin is considered as the largest nonreproductive
target on which estrogens and androgens act, El Safoury
et  al. [7] assumed a possible relationship between the
pathogenesis of skin tags and sex steroid balance. Another
phenomenon is the association of skin tags in obese
patients, which may  also be explained by the interplay of
sex  steroids and their receptors in skin tags.
In the current study, the age of skin tags cases ranged
from 17 to 65 years with mean age of 40.32 ± 14.01 years.
Correlation between skin tags number and age groups was
done,  it was statistically signiﬁcant. These results were sim-
ilar  to the ﬁndings of other studies which reported that
the  risk of getting skin tags and the mean number of STs
increased with age [19,20]. However, these studies found
that  ST increase in frequency, reached a peak value up to
the  5th decade, then they noticed stagnation or decline
in  this frequency. This decline after the ﬁfth decade was
not  detected in the current study; this may  be because of
that  the patients older than 50 years were all obese, same
ﬁnding  was reported by El Safoury and Ibrahim [20].
Regarding the gender in this study, there was  female
predominance; 20 cases were females and 5 were males,
this  may  be explained by the cosmetic concern of the
females who  ask more for medical advice. This result was
similar  to what Waisman [21] found in subjects with skin
tags,  it was  twice more frequent in women  than in men.
However some other studies did not found signiﬁcant sex
preference [19,20,22].
Considering the localization of skin tags in the cases in
the  present study, neck (96%) and axilla (44%) respectively
were the most common sites. These results went with other
studies  reported that skin tags were most commonly seen
on  the neck followed by the axilla then the groin and other
sites  [23,24]. However Mackie and Quinn [1] found that the
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Table 4
Relation between site and estrogen and androgen receptor staining in skin tags.
ER MCp
0 (n = 9) +1 (n = 7) +2 (n = 6) +3 (n = 3)
No % No % No % No %
Site
Neck 8 88.9 7 100.0 6 100.0 3 100.0 1.000
Axilla 5 55.6 3 42.9 2 33.3 1 33.3 0.938
Chest 1 11.1 2 28.6 0 0.0 0 0.0 0.632
Eye  lid 2 22.2 0 0.0 0 0.0 0 0.0 0.478
Infra-mammary 1 11.1 0 0.0 0 0.0 0 0.0 1.000
Thigh 1 11.1 0 0.0 0 0.0 0 0.0 1.000
AR IHC staining Test of sig.
−ve (n = 10) +ve (n = 15)
No % No %
Site
Neck 9 90.0 15 100.0 FEp = 0.400
Axilla  5 50.0 6 40.0 P = 0.622
Chest  1 10.0 2 13.3 FEp = 1.000
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REye  lid 2 20.0 
Infra-mammary 1 10.0 
Thigh  1 10.0 
ost frequent localization of skin tags were in the axilla
egion followed by the neck region.
According to family history in this study, thirteen
atients with skin tags (52%) had positive family history. In
 study done by Erkek et al. [25], a positive family history
as  obtained from (65.5%) of patients.
Considering the general medical condition of the
atients with skin tags in this study, majority of the patients
ad  obesity (72%); Diabetes mellitus (28%) and hyperten-
ion (28%) were equally presented. Thappa [26] found that
kin  tags have been associated with many diseases includ-
ng  DM and obesity. He also reported that the frequency of
T  had been found to co-exist with DM patients with a sig-
iﬁcant  relationship, and ST may  serve as a marker for DM.
However,  Kahana et al. [27], reported that skin tagsere not associated with increased incidence of obesity
ompared to the general population but reported that
hose  patients with skin tags had greater impairment
able 5
elation between number of skin tags and estrogen and androgen receptor staini
Number of skin tags 
<5 (n = 7) 5–10 (n = 5) 
No % No 
ER
0 2 28.6 4 
+1 3 42.9 0 
+2 2 28.6 0 
+3 0 0.0 1 
Number of skin tags 
<5 (n = 7) 5–10 (n = 5) 
No % No 
AR IHC staining
−ve  2 28.6 4 
+ve 5 71.4 1 0 0.0 FEp = 0.150
0 0.0 FEp = 0.400
0 0.0 FEp = 0.400
of carbohydrate metabolism and detection of skin tags
may  serve a cutaneous marker for identifying patients at
increasing risk of having DM.
Crook [28] conducted a study on patients who had skin
tags  and who also displayed an abnormal lipid proﬁle,
which is also known as the atherogenic proﬁle and is asso-
ciated  with insulin resistance, type 2 diabetes mellitus and
an  increased risk of cardiovascular disease.
In a study done on obese patients, the percentage of
those with STs increased with the severity of obesity [23].
In  a correlation between skin tags number and body mass
index  in this study, it was  noticed that there was increase in
number  of skin tags in obese and overweight patients but it
was  statistically insigniﬁcant. Rasi et al. [29] had found that
no  correlation was found between number of skin tags and
BMI,  while another study reported that the mean number of
skin  tags was signiﬁcantly higher among obese participants
in  comparison to the non-obese [20].
ng in skin tags.
MCp
>10 (n = 13)
% No %
80.0 3 23.1 0.267
0.0 4 30.8
0.0 4 30.8
25.0 2 15.4
MCp
>10 (n = 13)
% No %
80.0 4 30.8 0.192
20.0 9 69.2
oscopy a
[
[
[
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It was noticed in the current study that acanthosis nigri-
cans  (AN) had the higher percentage among associated
skin diseases that had been detected. It was detected in
eight  (32%) cases. Similar ﬁndings were also reported [23]
but  others showed no statistically signiﬁcant difference
between cases of skin tags with AN and those without [7].
Hormonal  factor in the pathogenesis of ST had been
suggested by some authors who found that skin tags may
be  aggravated by pregnancy and may  resolve postpartum
[4,30,31].
The role of estrogen and androgen receptors in patho-
genesis of skin tags was studied only by El-Safoury et al.
[7],  they investigated androgen receptors (AR), estrogen
receptors  (ER), and estrogen receptors  (ER) by
reverse transcription-polymerase chain reaction (RT-PCR).
To  the best of our knowledge the present study is the ﬁrst
immunohistochemical study for this subject.
In the present study, estrogen receptors were signiﬁ-
cantly positive in skin tags in contrast to perilesional skin
and  normal skin. Estrogen receptors scoring were moder-
ate  (+2) and strong (+3), nuclear immune staining in 24%
and  12% respectively in skin tags cases compared with ER
scoring  in perilesional and normal skin 0%.
Moreover, androgen receptors were also signiﬁcantly
positive, nuclear immune-staining in skin tags in 15
patients (60%), compared with perilesional skin in 4
patients (33.3%), and normal control (0%). These signiﬁ-
cant  results were in agreement with El Safoury et al. [7].
They  found that the level of estrogen receptors (both  and
)  was signiﬁcantly higher in skin tags than in controls.
They also found the same signiﬁcant upsurge for androgen
receptors in skin tags relative to control.
A correlation between age, sex and estrogen recep-
tor expression has been done in the current study and
there  was no signiﬁcant relation between neither age nor
sex  and estrogen receptor staining. In another study done
by  Auw-Haedrich and Feltgen [32], there was signiﬁcant
relation between age and ER expression but they found
no  difference in the proportion of cells of meibomian
glands expressing ERs between female and male patients.
Regarding age and sex in correlation with AR expression
in this study, no relation between age or sex and androgen
receptor staining in skin tags had been found.
In the current study there was no correlation between
DM and ER expression. On the other hand, several studies
have  reported a potential relationship between estrogen
and  glucose homeostasis in physiological and pathological
states as DM [33]. Also, there was no relation between nei-
ther  BMI  nor AN and ER expression in skin tags. This result
was  in agreement also with El Safoury et al. [7].
In the current study there was no relation between AR
immunostaining and DM.  Cao et al. [34], reported that AR
were  negatively correlated with the course of DM.
There was no relation between AR immunostaining and
AN.  In a study done by Charles et al. [35], the severity of
the  AN was directly related to the degree of hyperinsuline-
mia  and was not correlated to the level of androgens. They
suggested that the insulin resistance seen in obese acan-
thotic  subjects cannot be attributed to hyperandrogenemia
or obesity, since control subjects matched for severity of
androgen  excess or degree of obesity had much less insulin
[
[nd Ultrastructure 1 (2013) 76–83
resistance. Moreover, El Safoury et al. [7] reported that
there  was no signiﬁcant difference in AR level between
participants with acanthosis nigricance and those without.
However AR staining showed a signiﬁcant relation with
BMI  in this study, where 11 patients from 15 (73.3%) with
positive  AR staining were obese. This was similar to the
results  of Gustafson et al. [36], who  showed a strong rela-
tionship between two common polymorphisms in the AR
gene  and indices of central obesity, particularly in women.
The  results in the present study point out to a signiﬁcant
estrogen and androgen receptors nuclear expression,
associated with the development of skin tags. According
to  the results of this study, the signiﬁcant relationship
between estrogen receptors as well as androgen recep-
tors  and skin tags, may  represent a strong evidence
of the pathogenesis of sex hormones in this disease.
Further research involving larger series of patients is
recommended and it may  be useful to evaluate anti-
androgen or anti-estrogen therapy effect on the course
of  progress of skin tags.
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